Olema Pharmaceuticals, Inc. OLMA Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s return on invested capital?
- Olema Pharmaceuticals, Inc. (OLMA) reported return on invested capital of -52.9% in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?
- Olema Pharmaceuticals, Inc.'s return on invested capital increased by 0.2% year-over-year, from -53% to -52.9%.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s return on invested capital?
- Over 3 years (2022 to 2025), Olema Pharmaceuticals, Inc.'s return on invested capital has grown at a 2.3% compound annual growth rate (CAGR), from -47.5% to -50.9%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.